Alymsys 400 mg/16 mL (25 mg/mL) vial Images
Generic Name: bevacizumab
This medication has been identified as Alymsys 400 mg/16 mL (25 mg/mL) vial. It is supplied by Amneal Pharmaceuticals LLC.
Alymsys is used in the treatment of Glioblastoma Multiforme; Colorectal Cancer; Fallopian Tube Cancer; Cervical Cancer; Non Small Cell Lung Cancer and belongs to the drug class VEGF/VEGFR inhibitors. Risk cannot be ruled out during pregnancy. Alymsys 400 mg/16 mL (25 mg/mL) vial is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Alymsys
- Generic Name
- bevacizumab
- Strength
- 400 mg/16 mL (25 mg/mL) vial
- Availability
- Prescription only
- Drug Class
- VEGF/VEGFR inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amneal Pharmaceuticals LLC
- National Drug Code (NDC)
- 70121-0755
See also:
More about Alymsys (bevacizumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: VEGF/VEGFR inhibitors
- Breastfeeding
- En español
Patient resources
- Alymsys drug information
- Alymsys (Bevacizumab Intravenous) (Advanced Reading)
- Alymsys (Bevacizumab-maly Intravenous) (Advanced Reading)
Other brands
Avastin, Mvasi, Vegzelma, Avzivi, Zirabev
Professional resources
Other brands
Avastin, Mvasi, Jobevne, Vegzelma, ... +2 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.